Biocryst Pharmaceuticals Inc (BCRX)
Durham, NC
Total Compensation for Fiscal Year Ending in 2024: $8,317,286
| Salary | $705,536 |
|---|---|
| Bonus | $0 |
| Value of Stock Awards | $2,675,919 |
| Value of Option Awards | $4,002,134 |
| Non-Equity Incentive Plan Compensation | $899,558 |
| Change in Pension Value and Deferred Compensation Earnings | $0 |
| All Other Compensation | $34,139 |
| Total | $8,317,286 |
Biocryst Pharmaceuticals Inc disclosed its CEO pay was
30
times its median employee's pay for the fiscal year ending in 2024.
How Do You Compare?
